Admission Date:  [**2128-2-17**]              Discharge Date:   [**2128-3-2**]  Date of Birth:  [**2046-3-23**]             Sex:   F  Service: CARDIOTHORACIC  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 922**] Chief Complaint: chest pressure  Major Surgical or Invasive Procedure: [**2128-2-19**] cardiac catheterization [**2128-2-23**] Aortic valve replacement with a 21-mm [**Doctor Last Name **] Magna Ease aortic valve bioprosthesis, serial number [**Serial Number 31772**], model number 3300TFX.
Coronary bypass grafting times 1 with a reverse saphenous vein graft from aorta to the distal right coronary artery.
She was started on amiodarone but declined cardioversion, and spontaneously converted back into sinus rhythm prior to discharge.
She had taken atenololas directed and converted back to  sinus later that day.
She presented to the ED [**2128-2-13**] with epistaxsis; her INR was 6.7 and she was disharged home with coumadin on hold and returned for cardiac catherization for preoperative evaluation.
Past Medical History: Aortic Stenosis Atrial fibrillation Rheumatoid arthritis Hypertension Hypercholesterolemia PMR History of DVT COPD Hyperthyroidism Osteopenia Large ventral hernia Hearing loss C-Section x 3 Ventral hernia repair x 2   Social History: Lives with: Husband Occupation: Retired Tobacco:+Tobacco abuse - 1 pack per day since [**2062**] ETOH: no history of drug or alcohol abuse   Family History: Mother died of a ruptured AAA at age 70.
None [] Neuro: Grossly intact Pulses: Femoral      Right: 2+  Left: 2+ DP           Right: 1+  Left: 1+ PT           [**Name (NI) 167**]: 1+  Left: 1+ Radial       Right: 2+  Left: 2+  Carotid Bruit:  Right: soft bruit  Left: soft bruit   Pertinent Results: [**2128-3-2**] 04:36AM BLOOD WBC-10.2 RBC-3.29* Hgb-9.9* Hct-30.1* MCV-92 MCH-30.2 MCHC-33.0 RDW-16.0* Plt Ct-215 [**2128-2-17**] 09:19PM BLOOD WBC-14.5* RBC-3.59* Hgb-10.8* Hct-31.6* MCV-88 MCH-30.0 MCHC-34.1 RDW-12.8 Plt Ct-564* [**2128-2-17**] 09:19PM BLOOD Neuts-78.4* Lymphs-13.7* Monos-7.1 Eos-0.5 Baso-0.4 [**2128-3-2**] 04:36AM BLOOD Plt Ct-215 [**2128-3-2**] 04:36AM BLOOD PT-20.0* PTT-29.7 INR(PT)-1.8* [**2128-2-17**] 09:19PM BLOOD PT-20.2* PTT-39.3* INR(PT)-1.9* [**2128-2-16**] 09:50AM BLOOD PT-27.3* INR(PT)-2.7* [**2128-2-23**] 04:52PM BLOOD Fibrino-215 [**2128-3-2**] 04:36AM BLOOD Glucose-114* UreaN-35* Creat-1.3* Na-138 K-3.5 Cl-96 HCO3-37* AnGap-9 [**2128-3-1**] 06:13AM BLOOD Glucose-91 UreaN-38* Creat-1.4* Na-139 K-3.5 Cl-95* HCO3-36* AnGap-12 [**2128-2-27**] 02:02AM BLOOD Glucose-78 UreaN-31* Creat-1.9* Na-136 K-3.5 Cl-96 HCO3-28 AnGap-16 [**2128-2-16**] 09:50AM BLOOD UreaN-25* Creat-1.3* Na-135 K-4.8 Cl-97 HCO3-25 AnGap-18 [**2128-3-1**] 06:13AM BLOOD ALT-10 AST-31 LD(LDH)-316* AlkPhos-69 Amylase-33 TotBili-1.1 [**2128-2-19**] 07:35AM BLOOD ALT-32 AST-25 LD(LDH)-264* AlkPhos-93 Amylase-31 TotBili-0.6 [**2128-2-28**] 06:00AM BLOOD ALT-13 AST-40 AlkPhos-87 Amylase-33 TotBili-1.7* [**2128-3-2**] 04:36AM BLOOD Calcium-8.1* Phos-2.6* Mg-1.8 [**2128-2-17**] 09:19PM BLOOD Calcium-8.9 Phos-3.2 Mg-2.0  ABDOMINAL ULTRASOUND:  Liver parenchyma is homogeneous with no focal hepatic lesions.
Left kidney measures 10.2 cm and right kidney measures 10.8 cm with no hydronephrosis or stones noted.
HISTORY: 81-year-old female status post CABG and aortic valve replacement, postop day number 7.
Patient status post chest tube removal.
PA AND LATERAL CHEST RADIOGRAPHS: A right central venous catheter tip projects over the expected location of the upper SVC.
The right and left pigtail pleural drains have been removed.
Median sternotomy wires are intact.
Right central venous catheter, tip at upper SVC.
Echocardiographic Measurements Results  Measurements  Normal Range Left Ventricle - Septal Wall Thickness:  *1.3 cm  0.6 - 1.1 cm Left Ventricle - Inferolateral Thickness:  *1.3 cm  0.6 - 1.1 cm  Left Ventricle - Diastolic Dimension:  4.4 cm  <= 5.6 cm Left Ventricle - Ejection Fraction:  50% to 55%  >= 55% Aorta - Annulus:  2.2 cm  <= 3.0 cm Aorta - Sinus Level:  3.1 cm  <= 3.6 cm Aorta - Sinotubular Ridge:  2.2 cm  <= 3.0 cm Aorta - Ascending:  3.1 cm  <= 3.4 cm Aorta - Arch:  2.6 cm  <= 3.0 cm Aorta - Descending Thoracic:  *2.7 cm  <= 2.5 cm Aortic Valve - Peak Velocity:  *4.2 m/sec  <= 2.0 m/sec Aortic Valve - Peak Gradient:  *72 mm Hg  < 20 mm Hg Aortic Valve - Mean Gradient:  40 mm Hg Aortic Valve - LVOT VTI:  18 Aortic Valve - Valve Area:  *0.5 cm2  >= 3.0 cm2  Findings LEFT ATRIUM: No spontaneous echo contrast in the body of the [**Name Prefix (Prefixes) **] [**Last Name (Prefixes) **] LAA.
RIGHT ATRIUM/INTERATRIAL SEPTUM: A catheter or pacing wire is seen in the RA and extending into the RV.
Severely thickened/deformed aortic valve leaflets.
Bioprosthetic aortic valve prosthesis (AVR).
The patient was under general anesthesia throughout the procedure.
After INR decreased, she underwent cardiac catheterization, see report for further details.
She completed preoperatve workup and underwent aortic valve replacement and coronary artery bypass graft surgery on [**2128-2-23**].
Post operatively she was transferred to the intensive care unit for post operative management on milirone for heart failure but was weaned off in 48 hours.
Additionally she had episodes of rapid atrial fibrillation treated with betablockers and amiodarone.
She also had bilateral chest tubes placed on [**2-25**] due to respiratory distress and bilateral effusions.
She was improving however and was extubated [**2-26**], but creatinine increased to 1.9 peak [**2-27**] - acute kidney injury, and has trended down with creatinine 1.3 on discharge, which ace inhibitor was not initiated and should be considered as an outpatient.
She continued to make progress however had nausea with vomiting, and not tolerating oral intake.
She was resumed on liquid diet and advanced to regular diet with medications time spread out without any further nausea or vomiting.
She was ready for discharge to rehab on postoperative day eight with coumadin for atrial fibrillation.
Medications on Admission: AMIODARONE - 200 mg Tablet - 2 Tablet(s) by mouth DAILY (Daily)  BUPROPION HCL [BUDEPRION SR] - 150 mg Tablet Extended Release - 1 Tablet(s) by mouth once a day for 3 days and then twice a day there after HYDROXYCHLOROQUINE [PLAQUENIL] - 200 mg Tablet - 1 (One) Tablet(s) by mouth twice a day PRAVASTATIN [PRAVACHOL] - 20 mg Tablet - 1 Tablet(s) by mouth once a day WARFARIN - 2.5 mg Tablet - 1 Tablet(s) by mouth Once Daily at 4  PM ASPIRIN - (OTC) - 81 mg Tablet, Chewable - 1 Tablet(s) by mouth  once a day CALCARB 600 - 600 mg (1,500 mg) Tablet - 1 (One) Tablet(s) by mouth twice a day ERGOCALCIFEROL (VITAMIN D2) [VITAMIN D] - 1,000 unit Tablet - 1  Tablet(s) by mouth daily MULTIVITAMIN-MINERALS-LUTEIN [CENTRUM SILVER] - (OTC) - Tablet - 1 (One) Tablet(s) by mouth daily OMEGA-3 FATTY ACIDS [FISH OIL] - (OTC) - 1,000 mg Capsule - once a day   Discharge Medications: 1. bupropion HCl 150 mg Tablet Extended Release Sig: One (1) Tablet Extended Release PO BID (2 times a day).
2. pravastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
3. aspirin 81 mg Tablet, Delayed Release (E.C.)
4. hydroxychloroquine 200 mg Tablet Sig: One (1) Tablet PO twice a day.
Outpatient Lab Work Labs: PT/INR Coumadin for Atrial Fibrillation Goal INR 2.0-2.5 First draw [**3-3**] Then please do INR checks Monday, Wednesday, and Friday for 2 weeks then decrease to twice a week if on stable dosing Rehab physician to monitor and dose coumadin while at rehab - please arrange coumadin follow up with PCP prior to discharge from rehab 6. warfarin 1 mg Tablet Sig: goal INR 2-2.5 Tablets PO once a day: to be dosed by rehab physician based on INR results - received 1mg on [**3-31**], [**3-1**], [**3-2**] - INR [**3-2**] 1.8.
Zantac 150 mg Tablet Sig: One (1) Tablet PO once a day.
8. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
9. multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily).
10. acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4H (every 4 hours) as needed for fever, pain.
11. lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO Q4H (every 4 hours) as needed for constipatioon.
12. sodium chloride 0.65 % Aerosol, Spray Sig: [**12-7**] Sprays Nasal QID (4 times a day) as needed for dry nares .
13. albuterol sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: Three (3) ml Inhalation every six (6) hours as needed for shortness of breath or wheezing.
14. amiodarone 200 mg Tablet Sig: One (1) Tablet PO once a day.
15. metoprolol succinate 100 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily).
Lasix 20 mg Tablet Sig: One (1) Tablet PO once a day.
17. potassium chloride 10 mEq Tablet Extended Release Sig: One (1) Tablet Extended Release PO once a day.
18. ace inhibitor Unable to start while in hospital due to creatinine increase - please consider resuming as outpatient   Discharge Disposition: Extended Care  Facility: Hellenic - [**Location (un) 2624**]  Discharge Diagnosis: Aortic Stenosis s/p AVR Coronary artery disease s/p CABG Acute on chronic diastolic heart failure Acute kidney injury (peak cr 1.9) Atrial fibrillation Rheumatoid arthritis Hypertension Hypercholesterolemia Chronic obstructive pulmonary disease Hyperthyroidism Osteopenia Large ventral hernia Hearing loss   Discharge Condition: Alert and oriented x3 nonfocal Ambulating with assistance Incisional pain managed with tylenol Sternal Incision - healing well, no erythema or drainage Right leg - EVH and thigh incision with steri strips ecchymosis no drainage no erythema Edema none   Discharge Instructions: Please shower daily including washing incisions gently with mild soap, no baths or swimming until cleared by surgeon.
Look at your incisions daily for redness or drainage Please NO lotions, cream, powder, or ointments to incisions Each morning you should weigh yourself and then in the evening take your temperature, these should be written down on the chart  No driving for approximately one month and while taking narcotics, will be discussed at follow up appointment with surgeon when you will be able to drive No lifting more than 10 pounds for 10 weeks Please call with any questions or concerns [**Telephone/Fax (1) 170**] Females: Please wear bra to reduce pulling on incision, avoid rubbing on lower edge **Please call cardiac surgery office with any questions or concerns [**Telephone/Fax (1) 170**].
Answering service will contact on call person during off hours**  Labs: PT/INR Coumadin for Atrial Fibrillation Goal INR 2.0-2.5 First draw [**3-3**] Then please do INR checks Monday, Wednesday, and Friday for 2 weeks then decrease to twice a week if on stable dosing Rehab physician to monitor and dose coumadin while at rehab - please arrange coumadin follow up with PCP prior to discharge from rehab    Completed by:[**2128-3-2**
